Pharmavite Sitting Out Trendy Spin-Off Dance

"Otsuka is very, very committed to nutraceuticals generally, and supplements specifically,” says Pharmavite CEO Jeff Boutelle.

• Source: Shutterstock

Pharmavite LLC CEO Jeff Boutelle describes a recent acquisition by the firm as a “one plus one equals three dynamic” while also saying current numbers don’t add up for parent firm Otsuka Pharmaceutical Co. Ltd. to spin out Pharmavite.

“I can say with confidence, no time soon,” Boutelle told HBW Insight.

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Deals

More from Business